{"id":3442,"date":"2025-04-14T20:08:28","date_gmt":"2025-04-15T03:08:28","guid":{"rendered":"https:\/\/capca.ca\/document\/oncology-biosimilars-resources-for-healthcare-providers-2\/"},"modified":"2025-09-14T12:35:21","modified_gmt":"2025-09-14T19:35:21","slug":"ressources-sur-les-medicaments-biosimilaires-en-oncologie-a-lintention-des-fournisseurs-de-soins-de-sante","status":"publish","type":"document","link":"https:\/\/capca.ca\/fr\/document\/ressources-sur-les-medicaments-biosimilaires-en-oncologie-a-lintention-des-fournisseurs-de-soins-de-sante\/","title":{"rendered":"Ressources sur les m\u00e9dicaments biosimilaires en oncologie \u00e0 l\u2019intention des fournisseurs de soins de sant\u00e9"},"content":{"rendered":"\n<div>\n<div class=\"capca-container gb-element-48f41d2e\">\n<div>\n<p class=\"wp-block-paragraph\">Ce document de Sant\u00e9 Ontario (Action Cancer Ontario) est un premier point d\u2019information sur les m\u00e9dicaments biosimilaires pour les fournisseurs de soins de sant\u00e9. Il comprend des liens vers les ressources de l\u2019Initiative pancanadienne sur l\u2019utilisation des m\u00e9dicaments biosimilaires en oncologie.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"https:\/\/www.cancercareontario.ca\/fr\/lignes-directrices-et-conseils\/modalites\/traitements-biologiques\/medicaments-biosimilaires-fournisseurs\">Voir les ressources<\/a><\/p>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Ce document de Sant\u00e9 Ontario (Action Cancer Ontario) est un premier point d\u2019information sur les m\u00e9dicaments biosimilaires pour les fournisseurs de soins de sant\u00e9. Il comprend des liens vers les ressources de l\u2019Initiative pancanadienne sur l\u2019utilisation des m\u00e9dicaments biosimilaires en&#8230;<\/p>\n","protected":false},"template":"","meta":{"_acf_changed":false,"_crdt_document":"","_piecal_is_recurring":false,"_piecal_recurring_interval":1,"_piecal_recurring_frequency":"","_piecal_recurring_exact_position":false,"_piecal_recurring_end":"","_piecal_color":"","_piecal_text_color":"","_piecal_global_color_master":false,"_piecal_rsets":"[]","_piecal_is_event":false,"_piecal_start_date":"","_piecal_end_date":"","_piecal_is_allday":false,"inline_featured_image":false},"document-cancer-site":[],"document-capca-initiative":[198],"document-resource-type":[174],"document-topic":[],"document-treatment-modality":[194],"featured-item":[],"class_list":["post-3442","document","type-document","status-publish","hentry","document-capca-initiative-autre","document-resource-type-education","document-treatment-modality-medicaments-biosimilaires"],"acf":[],"_links":{"self":[{"href":"https:\/\/capca.ca\/fr\/wp-json\/wp\/v2\/document\/3442","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/capca.ca\/fr\/wp-json\/wp\/v2\/document"}],"about":[{"href":"https:\/\/capca.ca\/fr\/wp-json\/wp\/v2\/types\/document"}],"wp:attachment":[{"href":"https:\/\/capca.ca\/fr\/wp-json\/wp\/v2\/media?parent=3442"}],"wp:term":[{"taxonomy":"document-cancer-site","embeddable":true,"href":"https:\/\/capca.ca\/fr\/wp-json\/wp\/v2\/document-cancer-site?post=3442"},{"taxonomy":"document-capca-initiative","embeddable":true,"href":"https:\/\/capca.ca\/fr\/wp-json\/wp\/v2\/document-capca-initiative?post=3442"},{"taxonomy":"document-resource-type","embeddable":true,"href":"https:\/\/capca.ca\/fr\/wp-json\/wp\/v2\/document-resource-type?post=3442"},{"taxonomy":"document-topic","embeddable":true,"href":"https:\/\/capca.ca\/fr\/wp-json\/wp\/v2\/document-topic?post=3442"},{"taxonomy":"document-treatment-modality","embeddable":true,"href":"https:\/\/capca.ca\/fr\/wp-json\/wp\/v2\/document-treatment-modality?post=3442"},{"taxonomy":"featured-item","embeddable":true,"href":"https:\/\/capca.ca\/fr\/wp-json\/wp\/v2\/featured-item?post=3442"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}